M
Moshe Olshansky
Researcher at Baker IDI Heart and Diabetes Institute
Publications - 52
Citations - 2202
Moshe Olshansky is an academic researcher from Baker IDI Heart and Diabetes Institute. The author has contributed to research in topics: Cytotoxic T cell & T cell. The author has an hindex of 15, co-authored 47 publications receiving 1780 citations. Previous affiliations of Moshe Olshansky include Bar-Ilan University & University of Melbourne.
Papers
More filters
Journal ArticleDOI
Systematic identification of abundant A-to-I editing sites in the human transcriptome
Erez Y. Levanon,Erez Y. Levanon,Eli Eisenberg,Rodrigo Yelin,Sergey Nemzer,Martina Hallegger,Ronen Shemesh,Zipora Y. Fligelman,Avi Shoshan,Sarah Pollock,Dan Sztybel,Moshe Olshansky,Gideon Rechavi,Michael F. Jantsch +13 more
TL;DR: A computational search for ADAR editing sites in the human transcriptome is described, using millions of available expressed sequences and indicates the role of editing in controlling dsRNA stability.
Patent
Methods and systems for annotating biomolecular sequences
Alex Diber,Sarah Pollock,Zurit Levine,Sergey Nemzer,Vladimir Grebinsky,Brian Melon,Andrew Olson,Avi Rosenberg,Ami Haviv,Shaul Zevin,Tomer Zekharia,Zipi Shaked,Moshe Olshansky,Ariel Farkash,Eyal Privman,Amit Novik,Naomi Keren,Gad S. Cojocaru,Pinchas Akiva,Yossi Cohen,Ronen Shemesh,Osnat Sella-Tavor,Liat Mintz,Hanqing Xie,Dvir Dahary,Erez Y. Levanon,Shiri Freilich,Nili Beck,Wei-Yong Zhu,Alon Wasserman,Chen Chermesh,Idit Azar,Rotem Sorek,Jeanne Bernstein +33 more
TL;DR: Polypeptide sequences and polynucleotide sequences are provided in this paper, along with annotative information concerning such sequences and uses for these sequences and their sequences are annotated.
Journal ArticleDOI
A molecular threshold for effector CD8+ T cell differentiation controlled by transcription factors Blimp-1 and T-bet
Annie Xin,Frederick Masson,Frederick Masson,Frederick Masson,Yang Liao,Yang Liao,Simon Preston,Simon Preston,Tianxia Guan,Renee Gloury,Renee Gloury,Moshe Olshansky,Moshe Olshansky,Jian Xin Lin,Peng-Peng Li,Terence P. Speed,Terence P. Speed,Gordon K. Smyth,Gordon K. Smyth,Matthias Ernst,Matthias Ernst,Matthias Ernst,Warren J. Leonard,Marc Pellegrini,Marc Pellegrini,Susan M. Kaech,Stephen L. Nutt,Stephen L. Nutt,Wei Shi,Wei Shi,Gabrielle T. Belz,Gabrielle T. Belz,Axel Kallies,Axel Kallies +33 more
TL;DR: Overall, the data reveal two major overlapping pathways of effector differentiation governed by the availability of Blimp-1 and T-bet and suggest a model for cytokine-induced transcriptional changes that combine, quantitatively and qualitatively, to promote robust effector CD8+ T cell differentiation.
Journal ArticleDOI
Activation and In Vivo Evolution of the MAIT Cell Transcriptome in Mice and Humans Reveals Tissue Repair Functionality
Timothy S. C. Hinks,Timothy S. C. Hinks,Emanuele Marchi,M Jabeen,Moshe Olshansky,Moshe Olshansky,Ayako Kurioka,Troi J. Pediongco,Bronwyn S. Meehan,Lyudmila Kostenko,Stephen J. Turner,Alexandra J. Corbett,Zhenjun Chen,Paul Klenerman,Paul Klenerman,James McCluskey +15 more
TL;DR: In this article, the basic transcriptome of an activated mucosal-associated invariant T (MAIT) cell in both species and demonstrate how this profile changes during the resolution of infection and during reinfection.
Journal ArticleDOI
Granulocyte macrophage colony-stimulating factor induces CCL17 production via IRF4 to mediate inflammation
Adrian Achuthan,Andrew D. Cook,Ming Chin Lee,Reem Saleh,Hsu Wei Khiew,Melody W. Chang,Cynthia Louis,Andrew J. Fleetwood,Derek Lacey,Anne D. Christensen,Ashlee T. Frye,Pui Yeng Lam,Hitoshi Kusano,Koji Nomura,Koji Nomura,Nancy Steiner,Irmgard Förster,Stephen L. Nutt,Stephen L. Nutt,Moshe Olshansky,Stephen J. Turner,John A. Hamilton +21 more
TL;DR: Evidence is provided that GM-CSF can mediate inflammation and pain by regulating IRF4-induced CCL17 production, providing insights into a pathway with potential therapeutic avenues for the treatment of inflammatory diseases and their associated pain.